Australian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis
Open Access
- 5 October 2015
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 8 (1) , 1-8
Abstract
Osteoarthritis (OA) is a highly disabling and costly condition with an escalating prevalence in Australia due to the ageing and increasing obesity of the population. The general practitioner (GP) plays a central role in the management of this condition. The aim of this study was to examine opinions about the management of OA by Australian GPs following the release of the Royal Australian College of General Practitioners Guideline for the non-surgical management of hip and knee OA (RACGP OA CPG), and to compare the results with an earlier survey administered by the National Prescribing Service. In January 2013, a self-administered questionnaire was sent to 228 GPs to determine their treatment approaches to OA management using a clinical vignette of a patient with OA. This was compared with results from a similar survey undertaken in 2006. Seventy-nine GPs returned questionnaires (response rate 35 %). GP recommendations for paracetamol, a paracetamol/codeine compound, and oral non-steroidal anti-inflammatory drugs (NSAIDs) were consistent with recommendations in the RACGP OA CPG, and varied little from the previous survey. Notably, there was a marked increase between surveys in GP recommendations for tramadol (p = 0.004) and more potent opioids (p < 0.001). Advice about the adverse effects of NSAIDs and codeine and how to manage them increased between surveys (p = 0.038 and 0.005, respectively). For all non-pharmacological treatments, there were only minor changes in the percentage of GP recommendations when compared with the previous survey, however they remain underutilised. GPs generally demonstrated a conservative approach to the treatment of OA, however, the increased recommendations for more potent opioids warrants further investigation. Patients should be made aware of the risks of medications through the use of decision aids, which can provide structured guidance to treatment. Non-pharmacological interventions were not given the importance that is suggested by clinical practice guidelines.Keywords
This publication has 24 references indexed in Scilit:
- American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care & Research, 2012
- Patients' and Practitioners' Views of Knee Osteoarthritis and Its Management: A Qualitative Interview StudyPLOS ONE, 2011
- Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: engagement with information and perceptions of riskAge and Ageing, 2010
- OARSI recommendations for the management of hip and knee osteoarthritisOsteoarthritis and Cartilage, 2010
- Acupuncture for peripheral joint osteoarthritisCochrane Database of Systematic Reviews, 2010
- Response rates in postal surveys of healthcare professionals between 1996 and 2005: An observational studyBMC Health Services Research, 2009
- Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic ReviewClinical Cardiology, 2009
- Thou shalt versus thou shalt not: a meta-synthesis of GPs' attitudes to clinical practice guidelinesBritish Journal of General Practice, 2007
- Intraarticular corticosteroid for treatment of osteoarthritis of the knee2006
- How “bad” does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritisArthritis Care & Research, 2006